A detailed history of Kestra Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kestra Investment Management, LLC holds 3,789 shares of GILD stock, worth $401,482. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,789
Previous 2,508 51.08%
Holding current value
$401,482
Previous $210 Million 66.42%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$83.95 - $97.9 $107,539 - $125,409
1,281 Added 51.08%
3,789 $350 Million
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $167,007 - $210,646
2,508 New
2,508 $210 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $133B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kestra Investment Management, LLC Portfolio

Follow Kestra Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Investment Management, LLC with notifications on news.